產(chǎn)品名稱 | FITC標記的磷酸化雄激素受體抗體 |
英文名稱 | Anti-phospho-Androgen Receptor (Ser213)/FITC |
規(guī)格 | 100ul |
濃度 | 1mg/ml |
價格 | 來電可享受優(yōu)惠 |
英文名稱 Anti-phospho-Androgen Receptor (Ser213)/FITC
中文名稱 :FITC標記的磷酸化雄激素受體抗體
規(guī)格:100ul
說明書 100ul
產(chǎn)品類型磷酸化抗體
研究領(lǐng)域腫瘤 免疫學(xué)
抗體來源Rabbit
克隆類型Polyclonal
交叉反應(yīng) Human,
產(chǎn)品應(yīng)用IF=1:50-200
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分子量101kDa
性 狀Lyophilized or Liquid
濃 度1mg/ml
免疫原KLH conjugated Synthesised phosphopeptide derived from human Androgen Receptor around the phosphorylation site of Ser213 [ER(p-S)GA]
亞 型IgG
純化方法affinity purified by Protein A
儲存液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保存條件Store at -20 °C for one year.
別 名 Androgen Receptor (phospho S213); Androgen Receptor (Phospho-Ser213); Androgen Receptor (phospho Ser213); p-Androgen Receptor (Ser213); ANDR_HUMAN; HYSP1; AIS; Androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease); AR; DHTR; Dihydro Testosterone Receptor; Dihydrotestosterone receptor; HUMARA; Nuclear receptor subfamily 3 group C member 4; SBMA; SMAX1; Spinal and bulbar muscular atrophy; TFM.
